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Recent research has evaluated the effects of
lead exposure on responses of the hypothala-
mic–pituitary–adrenal (HPA) axis to acute
stress. These responses have been considered
in animals, through assessment of glucocorti-
coid blood levels before and after the onset
of an acute stressor. Several studies (Cory-
Slechta et al. 2004; Virgolini et al. 1999,
2004) have demonstrated a significant posi-
tive association in rats between Pb exposure
and baseline plasma corticosterone (the glu-
cocorticoid equivalent of cortisol in humans).
In addition, many studies have shown that
greater Pb exposure is associated with height-
ened corticosterone reactivity to acute stress
[Baos et al. 2006; Cory-Slechta et al. 2004;
Virgolini et al. 2004 (in rats)]; however, in
some cases, Pb exposure is associated with
either a diminished glucocoticoid response to
acute stress [Levesque et al. 2003 (in yellow
perch); Virgolini et al. 2004 (in rats)] or no
significant effect on acute stress reactivity
(Virgolini et al. 2004). To our knowledge,
the HPA response to acute stress as a function
of Pb exposure has not been evaluated in
humans. In the present study we consider
salivary cortisol response to acute stress, in
children with low-level Pb exposure.
Several studies have considered factors
that affect children’s adrenocortical responses
to acute stress. Such research has generally
focused either on intrinsic differences such
as temperament (van Bakel and Riksen-
Walraven 2004) and attachment (Gunnar
et al. 1989) or social contextual factors such
as parental maltreatment (Cicchetti and
Rogosch 2001) and abuse (De Bellis et al.
1994). Although exposure to environmental
toxicants may co-vary with these variables
(e.g., Gump et al. 2007), the study of toxi-
cant effects is relatively novel to developmen-
tal psychobiology. Similarly, the study of
acute stress responses in children is novel in
neurotoxicology. Notably, however, we
recently reported a positive association
between blood Pb and cardiovascular reactiv-
ity to acute stress in children (Gump et al.
2005). Here we consider the further associa-
tion of blood Pb to adrenocortical reactivity
to acute stress in these children.
Pb-induced increases in HPA reactivity in
children are likely to have far-reaching conse-
quences. The association of trace metal con-
centrations in blood with cardiovascular
disease has been assessed in various epidemio-
logic studies. Such studies suggest positive
associations between Pb and blood pressure
(Hu et al. 1996; Pirkle et al. 1985; Schwartz
1995), left ventricular hypertrophy (Schwartz
1991), and cardiovascular disease mortality
(Voors et al. 1982). The mechanism explain-
ing the associations between Pb and cardio-
vascular disease risk is not clear; however, it is
presumed to involve a number of systems that
regulate vasoconstriction and vasodilation,
including the HPA system (Rogers et al.
2003; Virgolini et al. 2005). Therefore, it
may be that Pb-induced increases in cardio-
vascular disease risk are produced partially by
underlying Pb-induced increases in HPA
responses to acute stress in children.
In addition to cardiovascular effects of Pb
exposure, low-level Pb exposure is associated
with cognitive deficits in children (Bellinger
et al. 2003; Canfield et al. 2003). In some
studies, HPA dysregulation and consequent
hypercortisolemia have shown a significant
negative association with cognitive function-
ing (McEwen 1998; Sapolsky 1996). There-
fore, low-level Pb exposure may cause chronic
elevations in cortisol levels and thereby pro-
duce cognitive deficits (cf. Cory-Slechta et al.
2004). The present research constitutes the
first step in testing these potential pathways,
by determining whether blood Pb levels
alter adrenocortical responses to acute stress
in children.
Methods
Participants. Participants were recruited in
the context of an ongoing longitudinal study
of the effects of environmental toxicants on
development (Lonky et al. 1996; Stewart et al.
2000). Of the 202 children currently enrolled
in the Oswego Children’s Study, we included
169 children (91 females and 78 males) in the
present study. Some children were not
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BACKGROUND: A few recent studies have demonstrated heightened hypothalamic–pituitary–adrenal
(HPA) axis reactivity to acute stress in animals exposed to heavy metal contaminants, particularly
lead. However, Pb-induced dysregulation of the HPA axis has not yet been studied in humans.
OBJECTIVE: In this study, we examined children’s cortisol response to acute stress (the glucocorti-
coid product of HPA activation) in relation to low-level prenatal and postnatal Pb exposure.
METHODS: Children’s prenatal blood Pb levels were determined from cord blood specimens, and
postnatal lead levels were abstracted from pediatrician and state records. Children’s adrenocortical
responses to an acute stressor were measured using assays of salivary cortisol before and after
administration of a standard cold pressor task.
RESULTS: Pb exposure was not associated with initial salivary cortisol levels. After an acute stressor,
however, increasing prenatal and postnatal blood Pb levels were independently associated with
significantly heightened salivary cortisol responses.
CONCLUSIONS: Our results suggest that relatively low prenatal and postnatal blood lead levels—
notably those below the 10 µg/dL blood lead level identified by the Centers for Disease Control
and Prevention for public health purposes—can alter children’s adrenocortical responses to acute
stress. The behavioral and health consequences of this Pb-induced HPA dysregulation in children
have yet to be determined.
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included because they were either not tested
with the stressor tasks (n = 25) or had missing
salivary cortisol samples (n = 8). Reasons for
not being tested included inability to schedule
within the testing window (n = 16), technical
problems (n = 4), and refusal (n = 5). Prenatal
Pb levels were available for 154 children and
postnatal Pb levels were available for 120 chil-
dren. The child’s response to an acute labora-
tory stressor was assessed within 2 weeks of
attaining 9.5 years of age, and the family was
paid $60 for participation in the current visit.
Acute psychological stressor. The child was
asked to submerge his or her dominant arm
in a 1-gal tub with one part ice to one part
water, for 1 min. This “cold pressor” task is
commonly used in protocols designed to test
neuroendocrine reactions to acute stress (e.g.,
Kapuku et al. 2002; Treiber et al. 1990).
Participants were informed of the time
remaining during the minute, to encourage
completion of the task, although the instruc-
tions for the task clearly informed the partici-
pants that they were free to withdraw the arm
if it became too painful. As a further precau-
tion, pain ratings (1 = not at all painful; 7 =
extremely painful) were assessed on a visual-
analogue scale every 10 sec, and participants
were reminded they were free to remove the
arm if and when they rated the experience as
a “5” or higher. The amount of time for
which the child kept the arm submerged (i.e.,
tolerance time) and the average pain rating
during the task were recorded. The cold pres-
sor task is known to reliably evoke an adreno-
cortical response, and was therefore always
administered first in the series of acute stress
tasks. Only 11.8% of children in our study
refused this task, defined as a tolerance time
< 20% of the full 1 min—or 12 sec. The
remaining children tolerated the cold pressor
for 40 sec, on average. Notably, this tolerance
time was not significantly associated with pre-
natal or postnatal lead exposure (p > 0.50).
After the cold pressor task, we administered
two cognitive stressors, mirror tracing and
reaction time tasks (in counterbalanced
order). As previously reported (Gump et al.
2005), these stressors were designed to assess
cardiovascular reactivity; they are not dis-
cussed further here. 
Procedure. On the day of testing, the par-
ticipant arrived at the laboratory at about 1630
hours (mean ± SD, 1628 ± 1.36) and before
beginning read and signed an assent form,
while his or her parents read and signed a sepa-
rate consent form approved by the Institutional
Review Board of SUNY Oswego. The labora-
tory session began with measurements of the
child’s height and weight. Each experimental
session comprised the following: a) an initial
rest period (10 min); b) a cold pressor task
(1 min of submerging the dominant arm in
ice water followed by a 2-min recovery);
c) an intertask rest (8 min); d) a choice reaction
time task (3 min); e) an intertask rest (8 min);
f ) a mirror-tracing task (90 sec; 5 trials); and
g) a final recovery/rest period (10 min).
Blood Pb measurements. Prenatal. Cord
blood specimens were collected at delivery
into 3-mL lavender top (Na2EDTA) evacu-
ated glass tubes. Over the course of the
study, both Vacutainer (Becton-Dickinson,
Franklin Lakes, NJ) and Monoject (Terumo
Corp., Ann Arbor, MI) tubes were used.
However, each lot of blood tubes and needles
used, regardless of source, was prescreened for
Pb contamination and was certified for blood
Pb measurements in the study by the analyz-
ing laboratory. Specimens were shipped to
the New York State Department of Health’s
Wadsworth Center and were analyzed for Pb
and erythrocyte protoporphyrin, a biochemi-
cal marker of Pb exposure. Each specimen
was analyzed for Pb in duplicate, using a
method based on electrothermal atomic
absorption spectrometry (ETAAS) with lon-
gitudinal Zeeman-effect background correc-
tion. The method has been fully validated
and is described in detail elsewhere (Parsons
and Slavin 1993). In summary, the method
detection limit (MDL) is 1 µg/dL, and the
repeatability—day-to-day precision—ranges
from 1.2 to 3.5% at blood Pb concentrations
around 10 µg/dL, and is typically < 2% above
20 µg/dL. At the mean blood Pb concentra-
tion measured in this study, the day-to-day
SD ranges from 0.1 to 0.3 µg/dL. The
method has been routinely cross-validated
against inductively coupled plasma mass
spectrometry, and traceability to SI units is
assured through analysis of standard reference
materials for blood Pb (Palmer et al. 2006).
The Wadsworth Center’s blood Pb labora-
tory is the New York State reference labora-
tory for this assay, and is responsible for
operating the New York State blood Pb pro-
ficiency testing program.
Postnatal. Postnatal blood Pb data were
collected for the children at an average
(± SD) age of 2.62 ± 1.20 years, through the
children’s pediatricians and county public
health agencies. New York State law requires
blood Pb testing for all children before enter-
ing kindergarten, and only those laboratories
certified by the New York State Department
of Health’s Wadsworth Center can accept
and analyze blood Pb specimens drawn in
New York State. Although more than 75 lab-
oratories are certified to perform blood Pb
testing in New York State, blood specimens
are typically sent to a variety of clinical labo-
ratories in both the commercial and public
health sectors, depending on local screening
practices and health insurance coverage.
Analytical techniques used for blood Pb are
ETAAS and anodic stripping voltammetry
(ASV). Specific laboratories used to analyze
specimens from children enrolled in the
Oswego Children’s Study included Quest
Diagnostics Clinical Labs in Norristown,
Pennsylvania, formerly SmithKline Beecham
(32% of specimens, analyzed by ETAAS);
Wadsworth Center, Albany, New York
(30.7%, analyzed by ETAAS); Oswego
Hospital Laboratory, Oswego, New York
(20%, analyzed by ASV); A. Lee Memorial
Hospital Laboratory, Fulton, New York
(10.7%, analyzed by ASV); Quest Diagnostics
Inc., Teterboro, New Jersey (4%, analyzed by
ETAAS); and SUNY Upstate Medical
University Clinical Pathology Laboratory,
Syracuse, New York (3%, analyzed by ASV).
These laboratories participate regularly in the
New York State proficiency testing program
that is organized by the Wadsworth Center
and are certified under both New York State
and federal regulations (Clinical Laboratories
Improvement Act 1988). Blood Pb levels
were determined on venous specimens for
79.9% of the reported data, with the remain-
der determined on capillary blood specimens.
Although capillary blood Pb measurements
can be compromised by contamination errors
during collection, the Wadsworth Center
has estimated that false positive errors,
defined as a false positive proportion, are
typically < 5% at 10 µg/dL (Parsons et al.
1997). The amount of background contami-
nation observed in 95% of capillary speci-
mens, though generally insignificant from a
clinical perspective (< 1 µg/dL), does give
rise to a larger relative error at concentrations
approaching the MDL.
For blood Pb results that were reported as
less than the MDL, we entered one-half the
value of the reported MDL for the corre-
sponding data points (cf. Schantz et al.
2001). For postnatal blood Pb, most children
had either one (n = 76) or two (n = 35) blood
Pb tests; however, a few children had three
(n = 9) or more (n = 2) tests before 9 years of
age. The median value was used for the chil-
dren with more than one draw. Blood Pb
levels in the Oswego cohort ranged from
1.5 to 13.10 µg/dL, with only six children
having blood Pb concentrations > 10 µg/dL,
the level defined by the Centers for Disease
Control and Prevention (CDC) as elevated
for public health purposes (CDC 1991).
Cortisol assessment. To measure adreno-
cortical reactivity, we collected saliva speci-
mens at four points during the stress protocol:
during the baseline period, twice after the
acute stress task (21 and 40 min after the start
of the cold pressor task), and during recovery
(60 min after the cold pressor task). Following
Kivlighan and Granger (2006), participants
were asked to imagine chewing a piece of their
favorite food, while moving their jaws as if
they were really chewing and to gently force
the pooling saliva through a short plastic straw
Gump et al.
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into a 5-mL cryovial. All specimens were
immediately frozen at –20°C until trans-
ported on dry ice to Pennsylvania State
University for cortisol assay.
On the day of testing, all specimens were
centrifuged at 3,000 rpm for 15 min to
remove mucins. Specimens were assayed for
salivary cortisol using a highly sensitive enzyme
immunoassay, cleared by the U.S. Food and
Drug Administration (2007, section 510k) for
use as an in vitro diagnostic measure of adrenal
function (Salimetrics, State College, PA). The
test used 25 µL saliva, had a lower limit of sen-
sitivity of 0.007 µg/dL, a range of sensitivity
from 0.007 to 1.8 µg/dL, and average intra-
and interassay coefficients of variation of < 5%
and 10%, respectively. All samples were
assayed in duplicate, and with the average of
the duplicates used for all test results. Cortisol
units are expressed in micrograms per deciliter.
To create a more normal distribution, we
eliminated a single outlier (with a value that
was > 3 SD above the mean for cortisol change
at both 40 and 60 min) and used a logarithmic
transformation (cf. Baos et al. 2006).
Cortisol levels follow a circadian cycle,
with peak levels in the morning, a steady
drop during the morning hours, and a rela-
tively stable plateau in the afternoon to early
evening. In addition, cortisol levels are
affected by recent meals. Therefore, all sub-
jects were scheduled to begin the protocol in
the afternoon (approximately 1630 hours)
and were given instructions to have no snacks
during the 1 hr preceding the testing. If the
child reported having had a recent snack, the
session was either rescheduled or briefly
delayed, depending on the timing of the
snack. In addition, participants were
instructed a) to avoid dairy products for
30 min before collections (restriction based
on evidence that some bovine hormones
cross-react in immunoassay), b) to rinse their
mouths with water 10 min before sample col-
lections (no snacks were provided between
sample collections), and c) to not brush their
teeth within 1 hr of testing, so as to avoid
blood contamination in saliva (two partici-
pants were rescheduled due to injuries or
surgery in the oral cavity within the preced-
ing 48 hr (Kivlighan et al. 2004).
Potential confounders. Psychosocial vari-
ables. To strengthen our inferences regarding
children’s blood Pb levels, we considered vari-
ous potential confounding variables, including
characteristics measured during pregnancy, at
birth, at 7 years of age, and at 9.5 years of age.
Measures included paternal height and weight,
maternal prepregnancy weight and height,
maternal weight gain during pregnancy,
maternal reported illness during pregnancy,
obstetric complications (using the Ballard and
a measure of optimality), head circumference
at birth, birth weight, gestational age, maternal
substance use during pregnancy (e.g., ciga-
rettes, alcohol), the Home Observation for
Measurement of the Environment (HOME),
the Clinical Epidemiological Studies–
Depression (CES-D; Radloff 1977) inventory,
the Four Factor Index of Social Status
(Hollingshead 1975) to measure socio-
economic status (SES), and body mass index
(BMI; weight (kilograms)/height (meters)2). A
complete list of these variables is provided in
Table 1. Because of skewed distributions, the
following measures were log-transformed
(using a base 10 log-transformation) before use
in any analysis: maternal illness (using an ill-
ness checklist); vitamin use during pregnancy
(number/week); prescription-drug use during
pregnancy (number/week); nonalcoholic sub-
stance use during pregnancy (specifically,
herbal tea, decaffeinated coffee, diet soda, and
decaffeinated soda in drinks/month); and
alcohol use during pregnancy (drinks/day).
Other toxicants. We considered other
potentially important prenatal toxicant
exposures by assessing cord blood levels of
Lead exposure and adrenocortical functioning
Environmental Health Perspectives • VOLUME 116 | NUMBER 2 | February 2008 251
Table 1. Relationships between covariates and salivary cortisol levels initially and after the onset of the
acute stressor.
Time after the onset of acute stress (min)
Covariate Initial level 21 40 60
Demographic
Maternal education 0.075 –0.028 –0.015 –0.049 
Paternal education 0.051 –0.030 0.045 –0.036
Parity of child 0.162** 0.014 0.049 0.068
SES score (1 year) –0.012 0.101* 0.012 0.009
SES score (9 years) 0.018 –0.137* –0.086 –0.122*
Maternal IQ –0.020 –0.035 –0.002 0.017
Maternal sustained attention (CPT) –0.045 –0.175** –0.136* –0.057
Maternal impulsive responding (CPT) –0.059 0.078 –0.021 0.030
Maternal depression (past) 0.034 0.106* 0.196* 0.188**
Maternal depression (current) –0.058 0.196** 0.147* 0.157*
Maternal age 0.071 –0.092 0.007 0.004
Maternal height –0.029 0.046 0.094 0.105*
Paternal age 0.209# –0.181* –0.025 –0.033
Paternal height –0.029 0.046 0.094 0.105*
Paternal weight 0.055 0.018 0.048 –0.027
HOME 1 year –0.148** –0.096 –0.016 0.063
HOME 4.5 years 0.018 –0.236** –0.119 –0.082
HOME 7 years –0.054 –0.159** –0.097 –0.087
No. of years at same address –0.116* –0.077 –0.011 0.001
No. of years near Great lakes 0.067 –0.040 0.031 0.033
Marital status –0.072 0.063 –0.041 –0.012
Child care –0.010 –0.070 –0.052 –0.026
Home care –0.165** 0.086 –0.103* –0.061
Health/nutrition
Prepregnancy weight –0.112* 0.035 0.081 0.087
Weight gain during pregnancy –0.006 0.095 0.072 0.047
Stress before pregnancy –0.006 0.010 –0.013 –0.015
Stress: 1st half pregnancy –0.166** –0.082 –0.082 –0.024 
Stress: 2nd half pregnancy –0.063 0.049 0.096 0.104*
Maternal illness history –0.139* 0.029 0.068 0.140*
Obstetric optimality –0.038 –0.013 0.015 –0.024
Vitamins during pregnancy 0.002 –0.022 –0.023 –0.006
Prescription meds. during pregnancy 0.032 0.034 0.055 –0.005
Nonprescription meds. pregnancy 0.012 0.040 –0.003 –0.006
Nutrition scale 0.025 0.047 –0.030 0.010
Child’s body mass index (age 9) –0.146** –0.039 –0.068 –0.046
Infant/birth characteristics
Child sex –0.039 0.093 0.211# 0.227#
Birth weight (g) –0.145* –0.061 0.006 0.078
Head circumference –0.143* –0.056 –0.017 0.031
Ballard: neuromuscular –0.078 –0.155** –0.033 –0.049
Ballard: physical –0.015 –0.139* –0.062 0.016
Gestational age at birth –0.133* –0.151* –0.052 0.001
Substance use
Cigarettes/day 0.085 –0.012 –0.054 –0.010
Secondhand smoke (hr/day) –0.116* 0.048 –0.026 –0.006
Alcohol (no. drinks/day) –0.062 0.033 0.007 0.068
Herbal tea (drinks/month) –0.141* –0.030 –0.105* –0.114*
Decaffeinated coffee (drinks/month) –0.111* –0.049 –0.046 –0.045
Diet soda (drinks/month) –0.117* –0.049 –0.046 –0.045
Decaffeinated soda (drinks/month) –0.044 0.132* 0.012 0.063
Caffeine beverages (drinks/month) 0.055 0.040 0.050 0.076
*p < 0.20, **p < 0.05, #p < 0.01
polychlorinated biphenyls (PCBs), 1,1-dichoro-
2,2-bis(p-chlorophenyl)ethylene (p,p´-DDE),
and hexachlorobenzene. We assessed mercury
levels from maternal hair cuttings, with position
along hair strands used to differentiate mercury
levels during the first and second halves of preg-
nancy. Further details on these other toxicant
measures can be found in prior publications
(Lonky et al. 1996; Stewart et al. 1999).
Data analysis. Data reduction. We com-
puted change scores for cortisol by subtract-
ing initial levels from the task means.
Therefore, our primary outcome variable was
change in cortisol at 21, 40, and 60 min
after the initiation of the cold pressor task.
Statistical treatment of potential con-
founders. A list of all the covariates considered
in the present analysis, and their correlations
with outcome measures, is shown in Table 1.
The decision rules for the inclusion of covari-
ates provide objective, comprehensive, and
rigorous control for potential confounders.
The method used in the current study is con-
sistent with that employed previously by us
(Darvill et al. 2000; Stewart et al. 2000, 2003,
2006) as well as by others (Jacobson and
Jacobson 1996). Any potential confounding
variables that were found to be even margin-
ally related (p < 0.20) to cortisol responses
served as covariates in all analyses. Several
studies (Maldano and Greenland 1993;
Mickey and Greenland 1989) have demon-
strated that this alpha level (0.20) is effective
in guarding against confounders in Monte
Carlo simulations. Use of this criterion also
allows major predictors of outcome to enter
the equation, even if such variables are unre-
lated to exposure. Statistical power is thereby
increased through reduction of the error term
in the regression equation (Kleinbaum et al.
1988). We determined relationships between
pairs of covariates and outcome through
single-pass, bivariate correlations between
each covariate and each outcome. Each corti-
sol assessment (in separate multiple regression
equations) was regressed on these covariates
and the residuals saved for use in subsequent
analyses. The number of covariates in these
equations varied from 16 to 6 (Table 1). This
number of predictors relative to subjects is
well within the 1:5 limits suggested by some
(Tabachnick and Fidell 1989) and provides
appropriate power for multiple regressions
with medium effect sizes (Green 1991).
To further minimize residual confound-
ing, we tested each covariate that failed to
meet the p < 0.20 entry criterion, to see
whether it affected the final outcome of the
analysis. Monte Carlo simulations have
empirically demonstrated that this additional
change-in-estimate criterion, whereby a
covariate is added to the equation if it changes
the association (beta coefficient) between
exposure and outcome by ≥ 10%, is an
extremely effective and rigorous means of
controlling residual bias in multivariate cor-
relational data sets (Maldano and Greenland
1993; Mickey and Greenland 1989). We pro-
ceeded to include all covariates that even mar-
ginally (> 10%) altered the outcome, even if
that outcome was already statistically signifi-
cant. We are thus afforded strong assurance
that no potentially important confounder was
excluded. This approach has been used suc-
cessfully in the Pb (Bellinger et al. 1992) and
PCB (Stewart et al. 2005, 2006) literature.
Every analysis, therefore, included all
covariates related to the outcome at p < 0.20,
and any remaining covariates that even mar-
ginally changed the relationship between
exposure and outcome (> 10% change in
beta) of that analysis. Only relationships that
were statistically significant after this two-
tiered approach were considered meaningful.
Statistical treatment of predictor variables
(blood Pb). Although the distribution of pre-
natal and postnatal blood Pb levels was nearly
normal, regression models can be sensitive to
the presence of outliers. In addition, use in the
analyses of a value of one-half the MDL for
postnatal blood Pb levels reported as below
the MDL, resulted in differing Pb values, as a
function of the testing laboratory’s MDL
(either 3 or 5). Therefore, as was done previ-
ously (Gump et al. 2005), we focused our
analyses on Pb quartiles but repeated these
analyses with Pb data as a continuous variable
(using SAS PROC REG; SAS Institute Inc.,
Cary, NC). For the analysis of quartiles, we
included all participants who had nonde-
tectable levels in the 1st quartile. For prenatal
Pb exposure, quartiles corresponded to the
following blood Pb levels: ≤ 1.0 (1st quartile;
n = 37), 1.1–1.4 µg/dL (2nd quartile; n = 39),
1.5–1.9 µg/dL (3rd quartile; n = 36), and
2.0–6.3 µg/dL (4th quartile; n = 42). For
postnatal Pb exposure, quartiles corresponded
to the following blood Pb levels: 1.5–2.8
µg/dL (1st quartile; n = 28), 2.9–4.1 µg/dL
(2nd quartile; n = 32), 4.2–5.4 µg/dL (3rd
quartile; n = 29), and 5.5–13.1 µg/dL (4th
quartile; n = 29). In the analyses of quartiles,
we used SAS PROC GLM (SAS Institute
Inc.) with a linear contrast to test the effects of
increasing blood Pb levels controlling for all
potential confounds (i.e., covariates).
Results
Potential confounders and salivary cortisol.
Table 1 presents prenatal, perinatal, and
other characteristics at the time of testing for
the children and their mothers in our cohort.
All children were tested within 2 weeks of
attaining 9.5 years of age. Bivariate correla-
tions are shown for each covariate across the
four cortisol specimens.
As a preliminary analysis, we conducted a
4 (blood Pb quartile) × 4 (time of saliva sam-
ple) mixed factorial analysis of variance, with
the saliva sample being a repeated measure.
Gump et al.
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Figure 1. Children’s unadjusted initial salivary cortisol levels (log-ng/dL) and after an acute stress task as a
function of quartiles of prenatal (A) and postnatal (B) Pb exposure.
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This analysis was initially performed for prena-
tal and postnatal Pb using a test for the linear
contrast across quartiles, but without covariate
control. These analyses revealed a significant
interaction between the time of the cortisol
sample and prenatal blood Pb levels, F (3, 411)
= 4.79, p < 0.005, as well as postnatal blood Pb
levels, F (3, 315) = 7.35, p < 0.0001. The
mean values from these analyses are shown in
Figure 1. After covariate adjustment, these
interactions remained significant for prenatal
[F (3, 393) = 3.19, p < 0.05] and postnatal
[F (3, 264) = 2.90, p < 0.05] Pb exposure. To
further analyze this interaction, we first consid-
ered initial adrenocortical levels as a function
of Pb exposure.
Initial adrenocortical levels and blood Pb
exposure. After adjustment for covariates, pre-
natal Pb quartiles were not significantly associ-
ated with initial cortisol levels, F (1, 142) =
0.01, p > 0.25. Similar results were obtained
when prenatal Pb levels were analyzed as a
continuous variable, F (1, 144) = 0.24,
p > 0.25. After adjustment for covariates, post-
natal Pb quartiles were not significantly associ-
ated with initial cortisol levels [F (1, 101) =
1.89, p > 0.15], nor were postnatal Pb levels
when analyzed as a continuous variable [F (1,
103) = 1.70, p > 0.15]. Having established
that initial levels of salivary cortisol were unaf-
fected by prenatal and postnatal Pb exposure,
we next analyzed changes from initial (i.e.,
reactivity) as a function of Pb exposure.
Adrenocortical responses to acute stress and
blood Pb exposure. Prenatal Pb exposure had a
significant effect on cortisol responses to acute
stress at 9.5 years of age, with increasing Pb
associated with an increasing cortisol response,
F (1, 134) = 11.78, p < 0.001 (for linear con-
trast). This association was equivalent for sam-
ples collected at 21, 40, and 60 min [F (2, 268)
= 0.28, p > 0.25 for the time × linear contrast
interaction]. The adjusted means for this
analysis are shown in Figure 2A. The effect of
prenatal Pb exposure was somewhat stronger
after additional adjustment for postnatal Pb
levels, F (1, 87) = 18.20, p < 0.0001.
Postnatal Pb exposure had a significant
effect on cortisol response to acute stress at
9.5 years of age, with increasing Pb associated
with an increasing cortisol response, F (1, 98)
= 11.21, p < 0.005. This association was again
equivalent for samples collected at 21, 40,
and 60 min [F (2, 196) = 1.89, p > 0.25, for
the time × linear contrast interaction]. The
adjusted means for this analysis are shown in
Figure 2B. The effect of postnatal Pb expo-
sure, although reduced, remained significant
after additional adjustment for prenatal Pb
levels, F (1, 83) = 4.06, p < 0.05.
We next performed regression analyses,
with covariates entered first, followed by Pb
levels as a continuous variable. As shown in the
upper row of Figure 3, prenatal Pb exposure
was significantly associated with cortisol reac-
tivity at 21 min [t (1, 147) = 2.97, p < 0.005],
40 min [t (1, 141) = 2.82, p < 0.01], and
60 min [t (1, 138) = 1.98, p < 0.05]. Similarly,
postnatal Pb exposure was significantly or mar-
ginally significantly associated with cortisol
reactivity at 21 min [t (1, 108) = 2.20,
p < 0.05], 40 min [t (1, 103) = 1.84, p < 0.10],
and 60 min [t (1, 102) = 2.31, p < 0.05], as
shown in the lower row of Figure 3. Notably,
PCB, mercury, and DDE levels were not sig-
nificantly associated with cortisol levels in these
children (p > 0.10).
Finally, we tested SES and sex as potential
effect modifiers, as found in previous research
on Pb-induced changes in glucocorticos-
teroids (Cory-Slechta et al. 2004). Neither
SES (measured at 1 and 9.5 years of age) nor
sex significantly interacted with prenatal or
postnatal Pb exposure effects (all p > 0.25). In
addition, the interaction between Pb exposure
timing (prenatal and postnatal) was not sig-
nificant [F (9, 75) = 1.10, p > 0.25]; however,
we do illustrate the additive nature of prenatal
and postnatal Pb exposure on mean cortisol
reactivity (adjusted for covariates) in Figure 4.
Discussion
In the present study we examined the rela-
tionship between children’s prenatal and
postnatal Pb exposures and subsequent
adrenocortical activity at rest as well as in
reaction to acute stress, measured at 9.5 years
of age. We found that initial cortisol levels
were not significantly associated with either
Lead exposure and adrenocortical functioning
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Figure 3. Children’s salivary cortisol reactivity (adjusted for covariates) at 21 (A, D) 40 (B, E), and 60 min (C, F ) as a function of prenatal (A–C) and postnatal (D–F)
lead exposure analyzed as continuous variables. Regression coefficients were β = 0.24, 0.24, 0.17, 0.25, 0.20, and 0.23 for A–F, respectively.
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prenatal or postnatal Pb exposure. This null
association with basal glucocorticosteroid levels
is consistent with findings in Pb-exposed
birds (Baos et al. 2006), although studies in
rats have shown increases in basal glucocorti-
coid levels in response to Pb exposure (Cory-
Slechta et al. 2004; Vyskocil et al. 1990). For
adrenocortical reactivity to acute stress, we
found a significant positive association with
both prenatal and postnatal Pb exposure.
Moreover, although prenatal and postnatal
Pb levels were positively correlated, their
effects on cortisol reactivity were indepen-
dent. Studies in animals have demonstrated a
similar positive association between lead
exposure and glucocorticoid reactivity (e.g.,
Baos et al. 2006; Cory-Slechta et al. 2004),
but we are not aware of any studies that have
yet demonstrated this association in humans.
The mechanism(s) for Pb effects on the
HPA axis are not well understood. Pb exposure
has been shown to affect the brain’s mesocorti-
colimbic dopaminergic system (Cory-Slechta
et al. 1997) and could thereby potentiate HPA
axis responses to stress (Cory-Slechta et al.
2004). Other possible mechanisms include
direct effects on the hypothalamus (Bratton
et al. 1994) or pituitary gland (Huseman et al.
1987), changes in brain catecholamine levels
within the hypothalamus (Virgolini et al.
2005), or alterations to cytokine levels
(Hemdan et al. 2005) and corresponding HPA
feedback (Marx et al. 1998). Pb exposure could
also indirectly affect cortisol levels via changes
in body weight (Scavo et al. 1988) or nutrition
(Giovannini et al. 1990) produced by
Pb-induced mood changes (Lisboa et al. 2005).
A few concerns related to the current study
should be noted. First, postnatal Pb was meas-
ured in various laboratories that used an MDL
of either 3 or 5 µg/dL, whereas prenatal Pb was
measured in just one laboratory using a single,
well-characterized method (Wadsworth
Center, NY) with an MDL of 1 µg/dL.
Therefore, the effect of prenatal Pb exposure
could have been stronger relative to postnatal
Pb effects, because a more sensitive and precise
measurement method (and corresponding
reductions in measurement uncertainty) was
used in a single laboratory for the prenatal
exposure assessment.
The second concern is the consistent effect
of Pb exposure across the 21-, 40-, and 60-min
cortisol specimens. If Pb exposure affects only
adrenocortical reactivity, and if 60 min is a suf-
ficient length of time for recovery, then Pb
exposure effects should have become attenu-
ated by 60 min after the acute stress task.
However, the effects of prenatal and postnatal
Pb exposure on cortisol reactivity were not sig-
nificantly different for the three cortisol sam-
ples. There are two possible explanations for
this pattern of findings. Either 60 min was
insufficient for the children’s recovery, or else
our initial level did not truly represent resting
adrenocortical activity. Although it is not
uncommon for salivary cortisol changes to
persist even after 60 min (e.g., Gruenewald
et al. 2004), recovery is typically expected by
45–60 min (Kuhn 1989). With respect to the
second possibility, establishment of a true
adrenocortical baseline is unfortunately not
straightforward. Studies have demonstrated a
positive association between adrenocortical
activity and exposure to a novel situation
(al´Absi and Lovallo 1993; Fishman et al.
1962), although not all studies have corrobo-
rated this association (Hertsgaard et al. 1992).
Our behavioral medicine protocol was quite
novel for the children enrolled in the Oswego
Children’s Study (a study primarily focused on
cognitive development), so it is quite possible
that the children’s salivary cortisol levels at
“baseline” were already elevated in response to
this unfamiliar situation. On the other hand,
direct comparisons between home and labora-
tory cortisol levels in young children have
shown lower cortisol levels in the laboratory at
baseline, relative to levels in the home (Gunnar
et al. 1989). Future testing should include
home cortisol assessment, to determine whether
the current protocol evokes differences from
home levels. Such a study would help deter-
mine whether Pb affects HPA reactivity or
HPA feedback sensitivity—an important dis-
tinction that would help direct future studies of
Pb-induced HPA dysregulation. For example, if
Pb exposure affects HPA feedback sensitivity,
Pb interference with type I and II corticosteroid
receptors or impaired glucocorticoid inhibition
of adrenocorticotropic hormone secretion
might be a target for future study.
That our assessment of postnatal Pb
occurred approximately 7 years before our
assessment of adrenocortical activity is a third
concern. However, multiple measures of Pb
over time have been shown in prospective
studies of children to be highly correlated (e.g.,
Wasserman et al. 2000). Furthermore, any
nonsystematic misclassification of postnatal Pb
levels due to this gap between the two assess-
ments would only underestimate the actual
association between postnatal Pb levels and
adrenocortical dysregulation.
Conclusions. The present study demon-
strated that prenatal Pb exposure was associ-
ated with a significant increase in the child’s
cortisol reactivity to acute stress at 9.5 years of
age. Comparable but independent effects on
cortisol reactivity were observed for postnatal
Pb exposure. Although the long-term implica-
tions for this association are unclear, they are
undoubtedly complex. Increased HPA axis
activity is associated with a number of emo-
tional, behavioral, and physical problems in
children (Charmandari et al. 2003). However,
chronic hyperactivity of the HPA axis (e.g.,
through chronic Pb exposure) could lead to
hypocortisolemia via reduced hormone
bioavailability and/or reduced sensitivity
(Raison and Miller 2003). Hypocortisolemia is
associated with a number of increased risks,
including post-traumatic stress disorder
(Delahanty et al. 2000; Yehuda et al. 1995a,
1995b), substance abuse (Moss et al. 1999),
and physical disease (Heim et al. 2000).
Therefore, it will be important to continue to
follow these children, and to determine the
consequences of these early effects of Pb expo-
sure on glucocorticoid reactivity. Furthermore,
future studies should consider cortisol reactiv-
ity as a potential mediator for disorders that
can be induced by Pb, such as fatigue (Lilis
et al. 1985), cognitive impairment (Canfield
et al. 2003), and immune disorders (Dietert
et al. 2002). Finally, the effects that we found
in the study were significant in a population
with low levels of Pb exposure, levels well
below the 10 µg/dL defined by the CDC as
elevated in young children.
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